Cimetidine Tablets Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 200 mg and 300 mg
Reference Brands: Tagamet(US & EU)
Category:
Gastrointestinal Drugs
Cimetidine is an H2-receptor antagonist that blocks histamine effects on gastric acid secretion. It reduces stomach acid, alleviates GERD, ulcers, and Zollinger-Ellison syndrome. Benefits include symptom relief, mucosal healing, decreased ulcer complications, and improved digestive comfort, supporting gastrointestinal health and preventing acid-related damage.
Cimetidine tablets is available in Injection
and strengths such as 200 mg and 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cimetidine tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cimetidine tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cimetidine tablets, marketed as Tagamet, are approved in the US by the FDA and in the EU via EMA for treating GERD, peptic ulcers, and Zollinger-Ellison syndrome. Regulatory approval requires detailed dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews comprehensive clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports swift approval, safe medication use, and worldwide availability, helping improve gastrointestinal health and prevent ulcer complications globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing